Literature DB >> 29673587

MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1.

Yong-Kang Shi1, Yu-Hua Guo2.   

Abstract

BACKGROUND: Accumulating evidence has suggested the crucial roles of differentially expressed miRNAs in osteosarcoma progression. MiR-139-5p was decreased in various cancers. However, the role of miR-139-5p in the development of osteosarcoma and the underlying mechanism remain to be addressed.
METHODS: MiR-139-5p and DNA methyltransferase-1 (DNMT1) mRNA expressions in osteosarcoma tissues and cells were detected by qRT-PCR and western blot analysis. The effects of miR-139-5p and DNMT1 on osteosarcoma cell migration, invasion and epithelial-mesenchymal transition (EMT) were investigated through cell migration and invasion assays, and western blot analysis. The relationship between miR-139-5p and DNMT1was explored using luciferase reporter analysis and western blot. A xenograft tumor model was employed to verify the effects of miR-139-5p on osteosarcoma.
RESULTS: We found that miR-139-5p was strikingly decreased in osteosarcoma tissues and cell lines. MiR-139-5p over-expression suppressed osteosarcoma cell growth, migration and invasion, while loss of miR-139-5p promoted osteosarcoma cell proliferation, migration and invasion. Following, we characterized that DNMT1 was a direct target of miR-139-5p that interacted with the 3'-untranslated region of DNMT1. MiR-139-5p regulated a down-regulation in DNMT1 protein expression levels. We also found that DNMT1 expression was increased and negatively correlated with miR-139-5p expression in osteosarcoma tissues clinically. Xenograft tumor analysis suggested that miR-139-5p over-expression reduced tumor growth in osteosarcoma in vivo through decreasing DNMT1 expressions.
CONCLUSION: MiR-139-5p suppressed the osteosarcoma progression by reducing DNMT1, supplying new insight into the molecular mechanism uncovering osteosarcoma growth.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  DNMT1; Invasion; Migration; Osteosarcoma; miR-139-5p

Mesh:

Substances:

Year:  2018        PMID: 29673587     DOI: 10.1016/j.bbrc.2018.04.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer.

Authors:  Fanye Zeng; Ning Yu; Yanyan Han; Julaiti Ainiwaer
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

2.  Downregulation of miR-588 is associated with tumor progression and unfavorable prognosis in patients with osteosarcoma.

Authors:  Tao Yu; Shuang Liang; Tianhong Ma; Weidong Song
Journal:  Exp Ther Med       Date:  2021-04-08       Impact factor: 2.447

3.  miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.

Authors:  Song Qi; Li Xu; Yongyuan Han; Hongkun Chen; Anyuan Cheng
Journal:  Cell Cycle       Date:  2022-05-31       Impact factor: 5.173

4.  The effect of dexmedetomidine on biological behavior of osteosarcoma cells through miR-1307 expression.

Authors:  Yanping Liu; Xiaopeng Gu; Yongtao Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Long non-coding RNA DHRS4 antisense RNA 1 inhibits ectopic endometrial cell proliferation, migration, and invasion in endometriosis by regulating microRNA-139-5p expression.

Authors:  Xuan Cui; Shisan Zhou; Yongtao Lin
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Dnmt1 is required for the development of auditory organs via cell cycle arrest and Fgf signalling.

Authors:  Dongmei Tang; Shimei Zheng; Zhiwei Zheng; Chang Liu; Jiner Zhang; Renchun Yan; Cheng Wu; Na Zuo; Lijuan Wu; Hongfei Xu; Shaofeng Liu; Yingzi He
Journal:  Cell Prolif       Date:  2022-03-29       Impact factor: 8.755

7.  Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression.

Authors:  Xu Qi; Xiao-Jun Yu; Xu-Ming Wang; Tie-Nan Song; Jie Zhang; Xin-Zhen Guo; Guo-Jun Li; Ming Shao
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-27       Impact factor: 8.886

8.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

Review 9.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

10.  MiR-139-5p influences hepatocellular carcinoma cell invasion and proliferation capacities via decreasing SLITRK4 expression.

Authors:  Jisiguleng Wu; Tong Zhang; Yubo Chen; Sigaowa Ha
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.